// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Impact of Night-Time Rapid Response Team Activation on Outcomes of Hospitalized Patients with Acute Deterioration

K. Kyeremanteng - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Mitochondrial Cyclophilin-D Regulates T Cell-Mediated Disease Tolerance to Tuberculosis

N. Khan - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

Can Upright Partitioned Exercise, Propulsion of a 3-Wheeled Scooter, Alter Leg Muscle Activity and Shift the Relationship Between Breathing and Leg Heaviness in Patients With Chronic Obstructive Pulmonary Disease (COPD)

T. E. Dolmage - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Implication of NUDT1 in Pulmonary Arterial Hypertension

A. Binabout - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Monocrotaline

PBI-4050 Therapy Selectively Improves Pulmonary Hypertension, Lung Remodeling and Right Ventricular Function in Heart Failure with Reduced Ejection Fraction

L. Gagnon - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

PBI4050

PBI-4050, a Novel First-in-Class Antifibrotic Agent, Improves Pulmonary Hypertension and Fibrosis, as Well as Right Ventricular Hypertrophy and Fibrosis in Monocrotaline-Treated Rats

Q. Nguyen - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Monocrotaline

PBI-4050, a Novel First-in-Class Agent, Improves Hypoxia/Sugen Induced Pulmonary Arterial Hypertension in Rats

Q. Nguyen - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Sildenafil citrate

The Efficacy of a Titrated Tongue Stabilizing Device on Obstructive Sleep Apnea

W. Alshhrani - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

End of Life Management and Palliative Care Use by Patients with Advanced Chronic Obstructive Pulmonary Disease (COPD)

A. S. Gershon - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Cholesterylester Transfer Protein (CETP) Gain-of-Function (GOF) Genotype R468Q and Development of Sepsis-Associated Acute Kidney Injury (AKI)

K. Roveran Genga - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

vasopressin Injection

Sex Differences and STAT6-Dependent Regulation of IL-33 Induced Eosinophilic Airway Inflammation and Alternatively Activated Macrophage Differentiation

H. Zhao - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Estrogens

Phagocytic Function of Different Lung Macrophage Phenotypes in COPD

K. Yamasaki - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Cytomegalovirus Infection Is Associated with Increased Mortality in the New Era of Antiviral Prophylaxis for Lung Transplant Recipients

G. Chandrarathne - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

TA-9070

Optimization of Oxygen Titration and Weaning with FreeO2: Update on Clinical Evaluation in More than 600 Subjects

F. Lellouche - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

An Innovative Point of Care Tool to Implement the 2017 GOLD Report in Practice

C. Poirier - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Factors Associated with Physicians’ Predictions of Long-Term Mortality of Critically Ill Patients

B. L. Ferreyro - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Variation in Ethics Approval and Contract Execution Processes in an International Observational Study of Mechanical Ventilation Discontinuation Practices: A Nested Study

K. Burns - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Asthma Control in Preschool Years Predicts the Likelihood of Subsequent Disease Remission

F. M. Ducharme - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

Adherence to a Mediterranean Diet Attenuates the Adverse Effect of Indoor Particulate Matter on Asthma Symptoms in Children

J. Rice - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Number of Asthma Emergency Department Visits as a Predictor of Asthma Hospitalizations in Children

S. Giangioppo - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved